Bcl-2 mRNA levels are inversely correlated with p53 protein levels. Total RNA was isolated from p53-expressing (AALEB and H23) and p53-deficient (SAOS-2) cell lines and bcl-2 mRNA detected by qRT-PCR. RNA levels are expressed as fold change from levels found in AALEB cells. 
Supplementary
Figure 2: p53 suppresses Bcl-2 expression independently of P2 by reducing bcl-2 mRNA stability. (A) Analysis of P2-dependent suppression of P1-M-P2 promoter activity by using p53-sufficient (A549) and -deficient (H1299) cells. The activities of the full length P1-M-P2 and the derived constructs containing serially shorter P2 promoter regions (P1-M #s 10-2) (see Table 1 in supplementary information) were analyzed. Firefly/Renilla luciferase activities of the deletion constructs were normalized to the full-length construct. (B) H1299p53 ts cells were transfected with the full-length P1-M-P2 and the derived constructs containing serially shorter P2 promoter regions (P1-M #s 10-2). (C) p53 sufficient (A549 and AALEB) and p53 deficient (H1299 and SAOS-2) cells were treated with 50ng/ml DRB and RNA isolated at 0, 2, 4, 8, 12, 24 h. Bcl-2 mRNA half-life was analyzed by qRT-PCR and normalized using 18SrRNA. The 5'UTR of the bcl-2 gene that is upstream of the TATA box was characterized by 5'RACE in primary normal human airway epithelial cells (HAECs). The P2 (B) and M (C) sequences are part of the 5'UTR. They were identified in DNase-treated mRNA isolated from p53 sufficient (A549) and p53 deficient (SAOS-2) cells by RT-PCR using primers specific to these regions. The M region was also detected by RT-PCR in DNase-treated mRNA isolated from A549 and H1299 cells transfected with either the fulllength P1-M-P2 (D), or the M-P2 (E), or M (F) -promoter luciferase constructs using primers specific to M and the luciferase sequences. (G) The P2 region cloned in the pCRII dual promoter vector was used to generate Bio-11-UTP-labeled sense and anti-sense RNA using the T7 and Sp6 promoters, respectively; the labeled RNAs were used in pull-down assays using S-100 cytosolic extracts prepared from H1299p53 ts cells. p53 was detected in protein extract (lane 1), and in pull-down products using sense (lane 2) but not anti-sense RNA (lane 3). (H) Sense RNA products containing either the entire P2 region (lane 1) or only the 16 nucleotide (-443/-429) region of bcl-2 mRNA pull down p53 (lane 2), but 4 nucleotide purine to pyrimidine substitutions (lanes 3, 4, 5, and 6) or 8 nucleotide substitutions (lanes 7 and 8) over the entire 16-nucleotide region abrogate the interaction with p53. Antisense mRNA synthesized from 16-nucleotide region upstream of (-608/-582) showed no interaction with p53 (lane 9). Supplementary Figure 4 : Suppression of Bcl-2 or SPDEF reduces mucin differentiation. HAECs were differentiated on air-liquid interface cultures and infected with retroviral vectors expressing shBcl-2 or empty control (A, B) or shSPDEF or shControl (C, D) . Western blot analysis showing reduced Bcl-2 (A) and SPDEF (C) protein levels in cells infected with shBcl-2 or shSPDEF compared with shCtrl. Expression of β-actin was used as loading control. MUC5AC mRNA levels were reduced when these cells were infected with shBcl-2 (B) and shSPDEF (D) when compared to shControl. RNA was isolated from the same membrane that was used to harvest protein and analyzed by qRT-PCR. Bars = group means ± standard error from the mean (n = 3 different treatments/group); * P<0.05. 

